State Of Wyoming Zentalis Pharmaceuticals, Inc. Transaction History
State Of Wyoming
- $754 Million
- Q4 2024
A detailed history of State Of Wyoming transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wyoming holds 34,716 shares of ZNTL stock, worth $77,416. This represents 0.01% of its overall portfolio holdings.
Number of Shares
34,716
Previous 15,454
124.64%
Holding current value
$77,416
Previous $56,000
87.5%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ZNTL
# of Institutions
147Shares Held
65.3MCall Options Held
43.2KPut Options Held
21.7K-
Matrix Capital Management Company, LP Waltham, MA14MShares$31.1 Million2.05% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$10.7 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.48MShares$9.98 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$7.29 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.22MShares$7.17 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $127M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...